Algernon Pharmaceuticals subsidiary Algernon NeuroScience is the first company in the world conducting human trials to test a sub-psychedelic dose of DMT to treat stroke.
- Күн бұрын
Algernon NeuroScience begins human trials using DMT to treat stroke
- Рет қаралды 110
Пікірлер: 2